This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Insulin resistance and chronic kidneydisease are both associated with increased coronaryarterydisease risk. Many formulae estimating glucose disposal rate in type 1 diabetes infer insulin sensitivity from c.
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronaryarterydisease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry. vs. 10.5%) and chronic kidneydisease (3.7%
Hypertension represents a major modifiable risk factor for coronaryarterydisease (CAD), heart failure (HF), stroke, chronic kidneydisease (CKD), and dementia.
The role of 4-hydroxynonenal (4-HNE), which is the most abundant stable product of lipid peroxidation, in vascular calcification has been poorly investigated.METHODS:Serum was collected from patients with chronic kidneydisease and controls, and the levels of 4-HNE and 8-iso-prostaglandin F2α were measured.
ABSTRACT: Albuminuria, an established biomarker of the progression of chronic kidneydisease, is also recognized as a biomarker for the risk of cardiovascular disease. Elevated urinary albumin excretion indicates kidney damage and systemic vascular disease, including myocardial capillary disease and arterial stiffness.
Heart bypass surgery, or coronaryartery bypass graft surgery (CABG), is performed to treat patients with severe coronaryarterydisease (CAD). Anemia of chronic disease : A type of anemia commonly seen in patients with long-term health conditions such as kidneydisease or heart disease.
Background Advanced chronic kidneydisease (ACKD) is common in patients undergoing percutaneous coronary intervention (PCI) and is associated with adverse outcomes. These patients are often excluded from revascularization studies. The goal of this study was to evaluate the impact of ACKD in patients undergoing PCI.
Secondary hypertension : This type results from an underlying condition such as kidneydisease, hormonal disorders, or the use of certain medications. CoronaryArteryDisease (CAD) : High blood pressure accelerates the development of CAD by promoting the buildup of plaques in the coronaryarteries.
Publication date: Available online 7 February 2025 Source: The American Journal of Cardiology Author(s): Nicholas Fialka, Ryaan EL-Andari, Jimmy Kang, Yongzhe Hong, Finlay A. McAlister, Jayan Nagendran, Jeevan Nagendran
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)
Methods A cohort of 1245 individuals without chronic kidneydisease from southwest China who underwent coronary angiography between February 2018 and June 2021 were enrolled. CTO was defined as a total occlusion of any coronaryartery or arteries for more than 3 months.
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronaryarterydisease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
Furthermore, in the multivariable logistic regression, we identified potential risk factors for myocardial injury in Omicron variant–infected elderly patients, including advanced age, pre-existing coronaryarterydisease, interleukin-6 > 22.69
BACKGROUND:Advanced chronic kidneydisease is associated with high cardiovascular risk, even after kidney transplant. CONCLUSIONS:Kidney transplant recipients are at high cardiovascular risk, despite a minority having obstructive coronaryarterydisease on MPI. year versus 3.6%/year
Among those ages 65 and older, nearly 50% who underwent limb amputation died within one year after surgery, according to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association.
Additional adjustment for mediators (hypertension, coronaryarterydisease, and chronic kidneydisease) marginally attenuated this relationship. T2D was associated with a greater adjusted hazard of HHF at younger ages (eg, HR at age 30 years: 6.94 [95% CI, 6.54–7.36]) 2.56]) relative to matched individuals.
All comorbidities, except for coronaryarterydisease (CAD), were more frequent in HF with preserved EF (HFpEF). 1.65), chronic kidneydisease (HR 1.37, 95%CI 1.34-1.41), 1.41), chronic obstructive pulmonary disease (HR 1.32, 95%CI 1.28-1.35).
Overall, it appears that rhythm control strategy in AF may be better in those with heart failure and in those with associated cardiovascular conditions and early AF.
Based on these results, updated diabetes guidelines recommend that in T2D patients with atherosclerotic cardiovascular disease, we should use GLP-1 RAs, and in T2D patients with heart failure or chronic kidneydisease, we should use an SGLT-2 inhibitor after first-line therapy with lifestyle and metformin [25]. Lavie, Carl J.,
“Prior studies have shown cardiovascular disease in persons living with HIV, however not at such an early stage,” said senior author Ahmed M. senior clinical investigator, and director of the Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and KidneyDiseases ( NIDDK ), in Bethesda, Maryland.
When comparing outcomes between TAVR and sAVR in patients with diabetes, TAVR patients were older and had a higher prevalence of chronic kidneydisease (CKD). Coronaryarterydisease was the most significant predictor of readmission in patients with diabetes.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content